25 Stocks Moving in Friday's Pre-Market Session

Gainers

• Sypris Solutions, Inc. SYPR shares rose 42% to $3.99 in pre-market trading after the company said its electronics unit has won a contract for deep space program.
• Conformis, Inc. CFMS rose 11.5% to $0.96 in pre-market trading after the company announced it received 510(k) clearance by the FDA for patient-specific instrumentation developed by the Company under its License Agreement and Development Agreement with Howmedica Osteonics.
• RiceBran Technologies RIBT rose 11.2% to $0.97 in pre-market trading. RiceBran Technologies will report Q1 results on Wednesday, April 28.
• Jaguar Health, Inc. JAGX rose 11.1% to $1.60 in pre-market trading. Jaguar Health recently announced the upsizing by $15.3 million of the at-the-market.
• Sigma Labs, Inc. SGLB rose 10.9% to $3.56 in pre-market trading after the company reported a narrower Q1 loss.
• Skechers U.S.A., Inc. SKX rose 10.3% to $49.10 in pre-market trading after the company reported better-than-expected results for its first quarter and issued strong Q2 guidance.
• Ocugen, Inc. OCGN shares rose 9.9% to $10.21 in pre-market trading after surging around 43% on Thursday. Earlier, on Wednesday, Ocugen’s co-development partner Bharat Biotech said that the second interim analysis of Phase 3 of Covaxin, a COVID-19 vaccine candidate, shows it demonstrated 78% efficiency in mild, moderate, and severe disease.
• 9 Meters Biopharma, Inc. NMTR rose 7.8% to $1.25 in pre-market trading after gaining over 7% on Thursday.
• Histogen Inc. HSTO rose 6.9% to $1.09 in pre-market trading.
• MicroVision, Inc. MVIS rose 6.4% to $13.98 in pre-market trading. MicroVision is expected to report its Q1 results on Thursday, April 29, 2021.
• Snap Inc. SNAP shares rose 6.4% to $60.68 in pre-market trading after the company reported better-than-expected Q1 sales and issued Q2 guidance. The company said Q1 daily active users surged 22% year over year.
• Mattel, Inc. MAT shares rose 6.3% to $22.20 in pre-market trading after the company reported better-than-expected Q1 results.
• Skillz Inc. SKLZ rose 6.3% to $17.61 in pre-market trading.
• Calliditas Therapeutics AB CALT shares rose 6.2% to $28.66 in pre-market trading after the company reported that the European Medicine Agency's Committee for Human Medicinal Products granted accelerated assessment procedure for Nefecon for the treatment of IgA Nephropathy.
• Marker Therapeutics, Inc. MRKR rose 5.7% to $2.26 in pre-market trading.
• BJ's Restaurants, Inc. BJRI rose 4.3% to $63.00 in pre-market trading after the company reported better-than-expected Q1 results.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• EDAP TMS S.A. EDAP fell 15.2% to $7.17 in pre-market trading after the company reported pricing of follow-on offering and also issued Q1 sales guidance.
• Quidel Corporation QDEL shares fell 14.8% to $103.98 in pre-market trading after the company reported weak preliminary revenue for the first quarter.
• Marathon Digital Holdings, Inc. MARA fell 9.5% to $28.10 in pre-market trading amid a decline in the price of Bitcoin. The company’s stock also dropped 11% on Thursday.
• Riot Blockchain, Inc. RIOT fell 8.6% to $33.34 in pre-market trading amid a decline in the price of Bitcoin. The company’s stock also dropped around 12% on Thursday.
• Canaan Inc. CAN fell 7.5% to $12.17 in pre-market trading. Canaan recently announced a customer order of 11,760 bitcoin mining machines.
• Shineco, Inc. TYHT fell 6.9% to $6.97 in pre-market trading after gaining over 12% on Thursday. Shineco, on April 14, entered into stock purchase agreements with investors.
• Bit Digital, Inc. BTBT fell 6.3% to $12.09 in pre-market trading amid a decline in the price of Bitcoin.
• MicroStrategy Incorporated MSTR fell 5.2% to $567.17 in pre-market trading. MicroStrategy is expected to report its Q1 financial results on Thursday, April 29, 2021.
• Intel Corporation INTC fell 2.9% to $60.81 in pre-market trading. Intel reported better-than-expected results for its first quarter and raised FY21 guidance. However, the company issued weak earnings forecast for the second quarter.